Request for Regional Data on Pseudoephedrine Sales and Methamphetamine Use

Sarah Burns made this Official Information request to Ministry of Health

The request was refused by Ministry of Health.

From: Sarah Burns

Kia ora,

Under the Official Information Act 1982, I request the following information for the period from January 2023 to the present:
1. A breakdown of pseudoephedrine-based medicine sales (e.g. Sudafed) by region, district, or town—particularly in:
• Waipukurau
• Napier/Hawke’s Bay
• Rotorua
• Other areas with significant increases in methamphetamine use, as identified through national wastewater data
2. Any internal analysis or reporting that compares pseudoephedrine sales data with methamphetamine detection trends (e.g. from ESR wastewater testing or Police data), including any assessment of:
• Regional correlations
• Risks of diversion for illicit manufacture
3. Any correspondence or concerns raised by pharmacists, health authorities, or law enforcement regarding unusually high sales of pseudoephedrine products in specific areas.

Please provide the information in electronic format. If any aspect of this request is considered too broad, I am happy to refine it.

Ngā mihi,

Sarah Burns

Link to this

From: OIA Requests


Attachment image.png
89K Download


Kia ora Sarah,

 

Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health on 19 May 2025. You requested:

 

"I request the following information for the period from January 2023 to
the present:
       1.      A breakdown of pseudoephedrine-based medicine sales (e.g.
Sudafed) by region, district, or town—particularly in:
       •       Waipukurau
       •       Napier/Hawke’s Bay
       •       Rotorua
       •       Other areas with significant increases in methamphetamine
use, as identified through national wastewater data
       2.      Any internal analysis or reporting that compares
pseudoephedrine sales data with methamphetamine detection trends (e.g.
from ESR wastewater testing or Police data), including any assessment of:
       •       Regional correlations
       •       Risks of diversion for illicit manufacture
       3.      Any correspondence or concerns raised by pharmacists,
health authorities, or law enforcement regarding unusually high sales of
pseudoephedrine products in specific areas."

 

The reference number for your request is H2025067232. As required under
the Act, the Ministry will endeavour to respond to your request no later
than 20 working days after the day your request was received:
http://www.ombudsman.parliament.nz/.   

 

If you have any queries related to this request, please do not hesitate to
get in touch ([1][email address]).

 

 

Ngā mihi 
 
OIA Services Team 
[2]Ministry of Health information releases 

show quoted sections

References

Visible links
1. mailto:[email address]
2. https://www.health.govt.nz/about-ministr...

Link to this

From: OIA Requests


Attachment Outlook guqjyftx.png
42K Download

Attachment image001.png
8K Download

Attachment image002.png
24K Download

Attachment image003.png
0K Download

Attachment image004.png
0K Download

Attachment image005.png
1K Download

Attachment image006.png
0K Download


Tēnā koe,

 

Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health – Manatū Hauora (the Ministry) on 19 May
2025 for information regarding sale of pseudoephedrine. You requested:    

   

“I request the following information for the period from January 2023 to
the present: 

1.                A breakdown of pseudoephedrine-based medicine sales
(e.g. Sudafed) by region, district, or town—particularly in: 

        •       Waipukurau 

        •       Napier/Hawke’s Bay 

        •       Rotorua 

        •       Other areas with significant increases in methamphetamine
use, as identified through national wastewater data 

2.                Any internal analysis or reporting that compares
pseudoephedrine sales data with methamphetamine detection trends (e.g.
from ESR wastewater testing or Police data), including any assessment of: 

        •       Regional correlations 

        •       Risks of diversion for illicit manufacture 

3.                Any correspondence or concerns raised by pharmacists,
health authorities, or law enforcement regarding unusually high sales of
pseudoephedrine products in specific areas.”  

 

The Ministry does not collect sales data of pseudoephedrine-based
medicines, therefore no internal analysis comparing the usage or detection
of methamphetamine to the sale of pseudoephedrine-based medicines exists.
As such, your request is refused under section 18(g)(i) of the Act, as the
information requested is not held by the Ministry and there are no grounds
for believing it is held by another agency subject to the Act. 

 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [1][email address] or by calling 0800
802 602.

 

 

Ngā mihi

 

OIA Services Team

[2]Manatū Hauora information releases

 
[3][IMG] [4][IMG] [5][IMG] [6][IMG]

 

show quoted sections

References

Visible links
1. mailto:[email address]
2. https://www.health.govt.nz/about-ministr...
3. https://www.facebook.com/minhealthnz/
4. https://twitter.com/minhealthnz
5. https://www.youtube.com/minhealthnz
6. https://www.linkedin.com/company/ministr...

Link to this

Things to do with this request

Anyone:
Ministry of Health only: